---
figid: PMC9698579__molecules-27-07668-g003
figtitle: Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9698579
filename: molecules-27-07668-g003.jpg
figlink: /pmc/articles/PMC9698579/figure/molecules-27-07668-f003/
number: F3
caption: Inhibition of the FAK/AKT signaling pathway and subsequently decrease EMT
  markers, CDH2 MMPs, etc., and increases epithelial marker, E-cadherin, which reduces
  cell invasion and migration by Renieramycin M and Carnosic Acid [,].
papertitle: Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?.
reftext: Sirajudheen Anwar, et al. Molecules. 2022 Nov;27(22):7668.
year: '2022'
doi: 10.3390/molecules27227668
journal_title: Molecules
journal_nlm_ta: Molecules
publisher_name: MDPI
keywords: epithelial-mesenchymal transition | cancer EMT | natural chemical entities
  | cancer | anticancer therapy | chemotherapy
automl_pathway: 0.9568206
figid_alias: PMC9698579__F3
figtype: Figure
redirect_from: /figures/PMC9698579__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9698579__molecules-27-07668-g003.html
  '@type': Dataset
  description: Inhibition of the FAK/AKT signaling pathway and subsequently decrease
    EMT markers, CDH2 MMPs, etc., and increases epithelial marker, E-cadherin, which
    reduces cell invasion and migration by Renieramycin M and Carnosic Acid [,].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PTK2
  - TIMP2
  - TIMP3
  - MMP14
  - MMP9
  - MMP7
  - MMP2
  - AKT1
  - AKT2
  - AKT3
  - MMP1
  - MMP3
  - MMP8
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - ITK
  - SLC22A3
  - CDH2
  - CDH1
  - FZR1
  - CBX8
---
